In summary, EV fractions of active UC patients elicit a significantly higher pro-inflammatory cytokine response in CD89 + CD14 + CD11b + U937 monocytes as well as in CD89+ primary human monocytes than EV fractions from non-IBD controls. The gene discussed is ITGAM; the disease is irritable bowel syndrome.